Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to cut opioid use in kidney donors

NCT ID NCT06764667

Symptom relief Sponsor: Indonesia University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two ways to manage pain in 60 people donating a kidney through keyhole surgery. One group received spinal anesthesia with added morphine, while the other got a nerve block near the lower back. The goal was to see which method reduces the need for opioid painkillers and improves recovery. The trial has already been completed.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Bupivacaine and Morphine
What this could lead to
If successful, this could point to a better way to manage pain after kidney donation, reducing the need for strong opioids.
What could go wrong
This is a small, completed study with 60 participants, so results may not apply to all patients. The two methods may show no significant difference.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Feb 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18-65 years undergoing laparoscopic donor nephrectomy * Patients with BMI ≤ 35 kg/m2 * Patients with American Society of Anesthesiology (ASA) physical status 1-2 * Patients who are willing to participate in this study Exclusion Criteria: * Cardiovascular disease (uncontrolled stage 2 hypertension, heart failure, arrhytmia) * Recent onset cerebrovascular diseasae of \< 3 months * Infection on spinal site * Coagulopathy * Elevated intracranial pressure * Severe renal or liver dysfunction * Valvular heart disease or atrioventricular block

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Laparoscopic donor nephrectomy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Laparoscopic donor nephrectomy Perioperative pain management

Contacts and locations

Locations

  • RSUP dr. Cipto Mangunkusumo

    Jakarta Pusat, Jakarta Special Capital Region, 10430, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.